CITIGROUP INC - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 70 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$2,105
-96.1%
1,224
-95.6%
0.00%
Q2 2023$53,912
-89.4%
27,647
-84.8%
0.00%
Q1 2023$507,253
+5.7%
182,465
+31.2%
0.00%
Q4 2022$479,726
+5896.6%
139,051
+4253.5%
0.00%
Q3 2022$8,000
+100.0%
3,194
+91.1%
0.00%
Q2 2022$4,000
-87.1%
1,671
-77.4%
0.00%
Q1 2022$31,000
-98.9%
7,403
-96.6%
0.00%
-100.0%
Q4 2021$2,774,000
+5448.0%
215,726
+4586.6%
0.00%
Q3 2021$50,000
+85.2%
4,603
+57.6%
0.00%
Q2 2021$27,000
-3.6%
2,921
-2.4%
0.00%
Q1 2021$28,000
-67.1%
2,993
-86.1%
0.00%
Q4 2020$85,000
+107.3%
21,459
+38.9%
0.00%
Q3 2020$41,000
-65.8%
15,444
-14.4%
0.00%
Q2 2020$120,000
+100.0%
18,052
+74.3%
0.00%
Q1 2020$60,000
-22.1%
10,357
+21.3%
0.00%
Q4 2019$77,000
+541.7%
8,541
+491.5%
0.00%
Q3 2019$12,000
-83.6%
1,444
-77.8%
0.00%
Q2 2019$73,000
+204.2%
6,501
+252.2%
0.00%
Q1 2019$24,000
-14.3%
1,846
+1.3%
0.00%
Q4 2018$28,0001,8230.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q3 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,102,929$18,059,047,0004.95%
Svennilson Peter 3,102,934$18,059,0002.29%
Casdin Capital, LLC 2,270,000$13,211,0001.40%
FRAZIER MANAGEMENT LLC 2,061,758$11,999,0001.36%
Redmile Group, LLC 3,068,194$17,857,0000.50%
Alphabet Inc. 929,022$5,407,0000.36%
Bleichroeder LP 169,039$984,0000.26%
Leap Investments LP 14,400$84,0000.12%
DAFNA Capital Management LLC 50,000$291,0000.12%
Blackstone Inc. 2,567,445$14,943,0000.11%
View complete list of GRITSTONE ONCOLOGY INC shareholders